BasselNazhaMDMPH

Oncology • Atlanta, GA

Genitourinary Oncology

Assistant Professor - Hematology & Medical Oncology - Emory University

Join to view full profile

Dr. Nazha is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nazha's full profile

Already have an account?

Office
550 Peachtree St NE
Ste 1820
Atlanta, GA 30308
Phone+1 404-778-1900

Education & Training

Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2020
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2017
Columbia UniversityMPH, Health Policy and Management, 2014
American University of Beirut Faculty of MedicineClass of 2013, MD
McGill UniversityBS, Biology, Great Distinction, 2008

Certifications & Licensure

GA State Medical License 2020 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma Start of enrollment: 2021 May 20
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Cabozantinib in Combination With Atezolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer Start of enrollment: 2024 Mar 05
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator
Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology Start of enrollment: 2023 Sep 26
Recruiting
Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

6 citations
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Tony Z Zhuang, Deepak Ravindranathan, Yuan Liu, Dylan J Martini, Jacqueline T Brown
The Oncologist. 2023-03-17
20 citations
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.
Dylan J. Martini, T. Anders Olsen, Subir Goyal, Yuan Liu, Sean Evans
Frontiers in Oncology. 2021-07-09
19 citations
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
Dylan J. Martini, Julie M. Shabto, Subir Goyal, Yuan Liu, T. Anders Olsen
The Oncologist. 2021-08-18

Press Mentions

The Case for Immunotherapy Trials That Reflect the Real World of Metastatic MelanomaSeptember 13th, 2019
With Millions at Stake, Oncologists Question Ethics of New Billing PracticeMay 14th, 2024

Other Languages

French, Arabic

External Links

Winship Cancer Institute profilehttps://winshipcancer.emory.edu/bios/faculty/nazha-bassel.html